Upload
ngotu
View
223
Download
2
Embed Size (px)
Citation preview
Bato Korać, Univerzitet u Beogradu, SrbijaTreći kongres o dijetetskim suplementima
25 - 26. novembar 2011.Beograd
Lupinus (lupins, lupines)
Scientific classification
Xiao Shi Xiong Huang San
Kingdom: Plantae(unranked): Angiosperms(unranked): Eudicots(unranked): Rosids(unranked): RosidsOrder: FabalesFamily: FabaceaeSubfamily: FaboideaeTribe: GenisteaeSubtribe: LupininaeGenus: LupinusSpecies: Lupinus albusSpecies: Lupinus albus
Lupinus albus
Protein39.70 %
Campos and El-Dash, Cereal Chem, 1978, 55:619-627.
(2-amino-5-guanidinovaleric acid)
1886: Schuize i Steiger; izolovan L-arginin iz sadnica (semena) lupina
1895: Hedin; L-arginin je komponentaproteina životinja.
1897: Schuize i Winterstein; pokazanastruktura L-arginina.
1924: Kossel i Gross; L-arginin je glavna amino kiselina baznih proteina spermatozoida riba.1930: Scull i Rose; sisari sintetišu L-arginin.1932: Krebs i Henseleit; uloga L-arginina u fiziologiji i metabolizmu.
• “Slao sam 240 pacijenata godišnje kardiologu. Od kada sam počeo sa korišćenjem L-arginina ja sam poslao jednog pacijenta u poslednje dve
di ” (J P d t)
; g g f g j
godine” (Joe Prendergast).
• 1988: Hibbs i sar.; NO je identifikovan kao biološki aktivni intermedijer L-arginin → nitrit+ nitrat puta u makrofaga.
Metabolic fates of arginine in mammalian cells
Wu and Morris JR, Biochem J, 1998, 336:1-17.
Nitric oxide timeline... 1 billion years ago78% N2 and 21% O2...
1847 Nitroglycerin A. Sobrero
1863 Dynamite A. Nobel
8 Nit l i l t W M ll
1979 NO cGMP, F. Murad
1975 nitroglycerin cGMP, F. Murad
1870 Nitroglycerin as coronary relaxant,W. Murrell
1987 EDRF NO, J.L. Ignarro
1980 EDRF, R.F. Furchott and J. Zawadski
1988 L‐arginine ‐NO, S. Moncada NO toxic gas
SENSATIONSENSATIONcommon air pollutant could be produced in cells and exert
SURPRISESURPRISE
… common air pollutant could be produced in cells and exert biological effects in higher animals such as mammals
… totally different from any other known signaling moleculeand very unstable
Nitric Oxide Synthase (NOS)
Homodimer, 130-150 KDa
• products of 3different genes
• 50-60% homology
NOS NOS M M
Nitric oxide synthase isoenzymes:
eNOS , nNOS, nM- µMiNOS, µM - mM
Nitric oxide synthase isoenzymes:
- Neuronal NOS (nNOS, NOS-I)- Inducible NOS (iNOS, NOS-II)
eNOS and nNOS - calcium sensitive
iNOS - calcium insensitive - Endothelial NOS (eNOS, NOS-III)- Mitochondrial NOS (mtNOS) mt NOS - organ specific different
splice variants
The potential role of the nitrate–nitrite–NO pathway in therapeutics
L-arginine
NO
Everything should be madeas simple as possible,
b t t i lbut not simpler.A. Ajnštajn
OPTION A 911 Call Free Ambulance Trip ($500-1000)* $1,000.00
OPTION B
•1 DPA Test $30 00p ( ) , ER Specialist Care/Treatment$350.00 EKG Test $366.00 Cardiac Catheterization $5,609.00 Open Heart or Brain Surgery $50,000.00
1 DPA Test $30.00•1 Month of Arginine $75.00•Peace of Mind Priceless
p g y $ ,(Angioplasty, Stent or Bypass)
Anesthesia Costs for 7 Hours $7,078.00 12 Hours in Recovery Room $2,895.00 2 Days in Intensive Care $5,292.00
Argininey $ ,
Hospital Stay ($1880 x 5) $9,400.00
Cost that vary which are not included) Salary/Leave Loss (while off work)Salary/Leave Loss (while off work) Medications Home Health/Hospice Care
Complete Funeral Arrangements $7500.00Complete Funeral Arrangements $7500.00(Programs, Casket, Plot, Services, etc)
Approximate Total $93,490.00 Actual Total $105
Interscapular Brown Adipose
Termogenicinactive tissue
Termogenicactive tissueAdipose
TissueIBAT
inactive tissue active tissue
4 ± 1 ºC22 ± 1 ºC
hyperplasticbrown
adipocyte
dormantbrown
adipocyteNorA βAR cAMP
C O L D
HEAT
UCP1
Is •NO involved in regulation of key thermogenic molecule expressionthermogenic molecule expression
45 days at 22±1 ºC Control
Mill Hillrat males
Untreated
1 3 7 12 21 d 45 L-arginine (2.25%)
L NAME (0 01%)
1, 3, 7, 12, 21 and 45 days at 4±1 ºC
L-NAME (0.01%)
NO-increased noradrenalin immunostaining and sympathetic innervation that could be one of possible ways of NO-acting in improvement of IBAT thermogeneis
Noradrenaline InnervationC 22°C 22°
day 1
day 3day 3
day 7
day 12
day 21
d 45day 45
Untreated L-arginine L-NAME Untreated L-arginine L-NAMEon cold
C 22°
L-arginine accelerated and prolonged cold-induced activation of PCNA as well asVEGF immunopositivity. L-NAME acted in the opposite way.
PCNA VEGF C 22°
day 1
day 3y
day 7
day 12
day 21
day 45
Untreated L-arginine L-NAME Untreated L-arginine L-NAMEon cold
L-arginine intensified cold-induced IBAT hyperplasia, blood flow and capillary remodeling. L-NAME acted in the opposite way.
cont
rol
untr
eate
dL-
arginine
E
day 1 day 3 day 7 day 12 day 21 day 45
L-NAM
E
Ekspresioni profili iNOS i eNOS proteina
Bez tretmana L-arginin L-NAME
iNOS
eNOS
L-arginine augmented, accelerated and prolonged cold-induced increase of thermogenic genes expression. L-NAME had an opposite effects.
Untreated L-arginine L-NAME
UCP1
PPARγPPARγ
PGC-1α
BAT
Fenotipske adaptacije u BAT koje omogućavaju metaboličke adaptacije (intenziviranje metabolizma)
BAT,4 ºC
BAT,
COLD
22 ºC
COLD
povećanje sadržaja UCP1, dekuplovanje
proliferacija prekursorskih ćelija
...UCP1.......PCNA
hipertrofija “zrelih” adipocita
povećanje protoka krvi, angiogeneza
sinteza DNA i proteina..... VEGF
......... PPARγ
PCNAsinteza DNA i proteina
Mitohondriogeneza ................. PGC-1α................PCNA
Cold-induced mitochondrial molecular and structural remodeling is intensified by L-arginine. L-NAME had an opposite effects.
Control Untreated L-arginine L-NAME
Control Untreated L-arginine L-NAME
room temperature 4 5 d a y – c o l d a c c l i m a t i o n
Group22 1 C 4 1 C 4 1 C 4 1 C
Mitochondrialnumber per
cell 66 ± 5 76 ± 4*
97 ± 5*** ###
61 ± 11###
Cristae number per
mitochondrion14 ± 1 18 ± 1
**22 ± 1
* #12 ± 1
###
Untreated L-arginine L-NAME
Complex I
Cyt cy
COX
Pathways of arginine synthesis
1, phosphate-dependent glutaminase;2 i 3, pyrroline-5-carboxylate synthetase;Step 4 is a spontaneous;p p ;5, ornithine aminotransferase;6, ornithine carbamoyltransferase;7, argininosuccinate synthase;8, argininosuccinate lyase;9 N acetylglutamate synthase;9, N-acetylglutamate synthase;10, carbamoyl-phosphate synthetase I;11, proline oxidase;12, aspartate aminotransferase;
Reactions 1-6 and 9-11 occur in mitochondria, reactions 7 and 8 take place in the cytosol, and reaction 12 can occur in both mitochondria and the cytosol.OAA, oxaloacetate;CP, carbamoyl phosphate.
Wu and Morris JR, Biochem J, 1998, 336:1-17.
Beneficial effects of dietary L-arginine supplementation on diet-induced obese rats
Size distribution of adipocytes from retroperitoneal adipose tissue of rats
McKnight et al., Amino Acids, 2010, 39:349-357.
Effects of dietary supplementation with arginineor N-acetylglutamate on concentrations of aminoacids in the plasma of weanling pigs
“Dietary supplementation with 0.6% L-arginine or 0.08% N-carbamylglutamate enhances intestinal growth and integrity, improvenutrition health and growth performance and the availability of dietary
Wu et al., Amino Acids, 2010, 39:831-839.
nutrition, health, and growth performance, and the availability of dietarynutrients for whole-body weight gain in postweaning pigs”.
6.2 μm 9.3 μm
Effects of dietary supplementation with arginine on intestinal morphology in rats
control 22 °C control 4 °C12.7 μm 9.3 μm
L-arginine 4 °CL-arginine 22 °C5 7 μm 4 4 μm5.7 μm 4.4 μm
L-NAME 4 °CL-NAME 22 °C
Experimental design
Non-diabetic
Control
L-arginine (2 25%)
Mill Hill
Non diabetic L arginine (2.25%)
L-NAME (0.01%)
Mill Hillrats
Control
Diabetic(alloxan, 120 mg/kg)
L-arginine (2.25%)
L-NAME (0.01%)
30,00
l / l)
Beneficial effects of L-arginine in pancreas of diabetic animals
20,00
entr
atio
n (m
mo
treatmentGlucose concentration
0,00
10,00
1 2 3Glu
cose
con
c
control level
200
diabetes diabetes + L-arginine diabetes + L-NAME
100
150
atio
n (m
mol
/ l)
control level
50
100
nsul
in c
once
ntra
Insulin concentration
01 2
In
diabetes diabetes + L-arginine diabetes + L-NAME
Vasilijević et al., J Physiol, 2007, 584:921933.
Non-diabetic Diabetic
Beneficial effects of L-arginine in pancreas of diabetic animals – Insulin immunopositivity
Control
L-arginineL arg n ne
L NAMEL-NAME
Non-diabetic Diabetic
Beneficial effects of L-arginine in pancreas of diabetic animals – PDX-1 immunopositivity
Control
L-arginineL-arginine
L-NAME
Non-diabetic Diabetic
Beneficial effects of L-arginine in pancreas of diabetic animals – Insulin/PDX-1 colocalization
Control
L-arginineL-arginine L-arginine-NO producing pathway
plays a role in t i f restoring of
insulin-producing cells acting as a
positive modulator L-NAME positive modulator of PDX-1 in
diabetic pancreas.
Non-diabetic Diabetic
Beneficial effects of L-arginine in pancreas of diabetic animals – nNOS immunopositivity
ControlControl
L-arginine
L-NAME
Beneficial effect of L-arginine in
di b i i L-NAME diabetic pancreas is mediated by nNOS.
Vasoregulation Nitrergic inervation
nNOS
LL--argininarginineNOS
··NONOnNOSnNOS
Exocrine secretion Endocrine secretion
.NO i O2.-, rapidno reaguju. Konstanta brzine ove reakcije je 3 puta
veća od konstante brzine reakcije dismutacije O2.-, katalizovane SOD.
Km 2x109 M-1s-1
Km 6.7x109 M-1s-1
Redoks status je specifično moduliran primenom sintetskogRedoks status je specifično moduliran primenom sintetskogmimetika superoksid dismutaze - [MnII(pyane)Cl2]
.
Heptakoordinovani Mn-makrociklični SOD mimetik [MnII(pyane)Cl2]
Experimental design
Untreated
[Mn(pyane)X2]
Non-diabetic
Mill Hillrats
[Mn(pyane)X2](5mg/kg)
Untreated
Diabetic
[Mn(pyane)X2](5mg/kg)
Diabetic(aloxan, 120 mg/kg)
(5mg/kg)
Beneficial effects of SOD mimics in pancreas of diabetic animals
100 Control100
tion
(mm
ol /
l)
Control
Diabetes
Diabetes + SOD mimic
50ul
in c
once
ntra
tControl level
01 2
Insu
Control Diabetes Diabetes + SOD mimic
Beneficial effects of SOD mimic in pancreas of diabetic animals – Vascularity
Control Diabetes Diabetes + SOD mimic
Beneficial effects of SOD mimics in pancreas of diabetic animals– NO metabolites -
Beneficial effects of SOD mimics in pancreas of diabetic animals– NO metabolites -
Nit it h lNitrite S-nitrosothiols
cGMP eNOS mRNA level
I
KontrolaTirodovmedijum
0h
Spermatozoidiič ih
j
normospermičnihpacijenata (30)
3h, 37°C %
Tirodov medijum Bez tretmana
6% CO2
Tirodov medijum 50 M SOD i tiksa 50 µM
[MnII(pyane)Cl2]SOD mimetik
[MnII(pyane)Cl2] povećava koncentraciju .NO u spermatozoidima
Kontrola Bez tretmana [MnII(pyane)Cl2]Kontrola Bez tretmana [Mn (pyane)Cl2]
Diamino-fluorescein-2-diacetat (Daf2-DA)
Mitochondrial functionality determines sperm quality
spermatogeneza
pokretljivost
spermatogeneza
hiperaktivacija
kapacitacijakapacitacija
vezivanje zazona pelucidu
Ca 2+
signaling
sintezaproteina
zona pelucidu
akrozomalnareakcija
fuzija saoocitom reakc jaoocitom
Sousa et al., PLos One, 2011.
Kontrola Bez tretmana [MnII(pyane)Cl2]
II Fragmentacija - najuočljiviji defekt ranih in vitro embriona,jasan i prihvaćen indikator lošeg kvaliteta embriona
K NF VF
sazrevanjep pt
< 30% > 50%
joociteapoptoza
ATPROS/RNSfragmentacija fertilizacija
razvoj ranogembriona
implantacija
Distribucija mitohondrija u blastomerama preimplantacionih embriona(MT-G)( )
Embrion bez fragmentacije Delimično fragmentisan embrionEm n z f gm n j D m n f gm n n m n
Blastomere delimično fragmentisanih preimplantacionih embrionakaraterišu se poremećenom, nejednakom distribucijom mitohondrija i .NO
Distribucija mitohondrija, MT-G
Distribucija .NO, Daf2-DA
TEM
eNOSiNOS
nNOS
TEM
Lokalizacija nNOS u mitohondrijama koje šse grupišu u klastere i povezuju sa
membranom vakuola obrazujućistrukture koje svedoče o njihovojeliminaciji fizičkom ekstruzijomj j
potvrđuje uključenost NO u fragmentaciji
Imunocitohemijska detekcija izoformi NOS u fragmentisanim embrionima
B e o g r a d s k a š k o l a f i z i o l o g i j e
1910.
Ivan Đaja1884 – 1957.
University of BelgradeInstitute for Biological Research
Dr Biljana BuzadžićDr Vesna OtaševićDr Ana StančićDr Aleksandra Janković
Faculty of BiologyCenter for Electron Microscopy
Milica Vučetić, PhD student
Center for Electron Microscopy
Dr Aleksandra KoraćKsenija Veličković, PhD studentMilica Markelić PhD studentMilica Markelić, PhD studentIgor Golić, PhD student
Anita Lazarević, BScMaja Bogdanović, BSc
University of Erlangen –Nurnberg GermanyNurnberg, Germany
Dr Ivana Ivanović-BurmazovićDr Miloš Filipović